Skip to Main Content

Paper Details

Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.
Cancer Epidemiol Biomarkers Prev
17
2018
Oligomenorrhea, Ovarian Cancer, PCOS, Polycystic Ovary Syndrome, Polycystic ovary syndrome, Women, borderline ovarian disease, histologic, histologic subtype, invasive ovarian cancer, oligomenorrhea, ovarian cancer, serous, serous and mucinous tumors, serous borderline tumors, women
Author NameAffiliation
Holly R HarrisFred Hutchinson Cancer Research Center
Mary Anne RossingFred Hutchinson Cancer Research Center
Mary Anne RossingUniversity of Washington
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Marc T GoodmanCommunity and Population Health Research Institute, Cedars-Sinai Medical Center
Joellen M SchildkrautThe University of Virginia
Andrew BerchuckDuke University Medical Center
Elisa V BanderaRutgers Cancer Institute of New Jersey
Nicolas WentzensenNational Cancer Institute
John R McLaughlin
Hoda Anton-CulverUniversity of California Irvine
Hoda Anton-CulverUniversity of California Irvine
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Anna H WuKeck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
  • 1 - 20

Datasets

Release 1.2